Panagora Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Panagora Asset Management’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-97	Closed	-$13K	–	3121
2020 Q4	$13K	Hold	97	–	–	﹤0.01%	2260
2020 Q3	$5K	Buy	+97	New	+$4.36K	﹤0.01%	2473

Panagora Asset Management's EIDX Position: Q1 2021 in Review

Panagora Asset Management sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 97 shares — an estimated $13K sold.

Panagora Asset Management first reported a position in EIDX in Q3 2020 and held it in 2 quarters. The position peaked at $13K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Panagora Asset Management reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Panagora Asset Management sold 97 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $13K.
Panagora Asset Management first reported a position in Eidos Therapeutics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
Panagora Asset Management's Eidos Therapeutics, Inc. Common Stock position peaked at $13K in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.